Calculate Your Salary Ranking
Home > Ophthotech Salary

Ophthotech Salary
  • 41
  • 98
  • 84

Ophthotech average salary is $-, median salary is $- with a salary range from $- to $-.
Ophthotech salaries are collected from government agencies and companies. Each salary is associated with a real job position. Ophthotech salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
-
Average
-
Median
-
High
-
Total 0 Ophthotech Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Ophthotech Jobs
See more Ophthotech Jobs »
  • Supply Chain Analyst
    Reconciling Ophthotech ERP inventory to material stored at a TPO on a scheduled basis. Commercial Supply Chain Analystu2013 API and Drug Product Manufacturing....
  • Temporary Senior Accountant/Accounting Manager
    *APPLY ONLINE AT WWW.OPHTHOTECH.COM/CAREERS* *_TEMPORARY POSITION EXPECTED TO LAST FOR 4-5 MONTHS_* *Position Summary* : This position is primarily
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Ophthotech Salaries (May 29, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Ophthotech salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Ophthotech Information
  • Ophthotech Corp
  • Industry: Major Drugs
  • City: Princeton, NJ
  • Ophthotech Corp. is a privately held biopharmaceutical company focused on developing and commercializing therapies for back-of-the-eye diseases. Ophthotech plans to develop a pipeline of compounds with strong scientific foundations for the treatment of AMD and bring them to market in an accelerated manner. In August of 2007, Ophthotech announced a Series A venture financing and two separate in-licensing deals with Archemix Corp. and (OSI) Eyetech. A third in-license from Biogen Idec and PDL BioPharma was announced in January of 2008. Ophthotech's venture investors include SV Life Sciences, HBM BioVentures and Novo A/S. For more information, please visit http://www.ophthotech.com.